Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.
about
Right upper quadrant pain and mass in a 41-year-old previously healthy man: a presenting feature of HIV-associated extranodal diffuse large B cell lymphoma with cardiac involvement.Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement.Comparison between presence of epstein barr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience.A rare case of the upper extremity diffuse large B-cell lymphoma mimicking soft tissue sarcoma in an elderly patient.Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.Primary sternum diffuse large B-cell lymphoma: A case report and review of the literature.Rare case of primary pleural lymphoma presenting with pleural effusion.Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas.Comment on "Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial".Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer's ring in remission after anthracycline-containing chemotherapy.A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma.Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma.High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large B-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi s
P2860
Q30416892-7DAD2974-1F93-4E4C-97B7-CD8D02ACFFD2Q36279071-E7A70FA0-6D04-4169-9E13-BDB9253D30D8Q36655534-55BD9DFC-27AB-41F8-A0E3-3BA6D2E8627CQ37119773-AF3BA70B-513E-4B32-97E4-321062990034Q37644528-97853620-D1FB-4FFA-ACCA-DD150CF68633Q38430165-3FABA407-17BE-42DC-B314-9A24D681FED5Q38542083-6E6DC0E7-6F50-4673-BA3E-E7E4178E3817Q40816919-F512B706-DDAC-4551-B341-EB70FE382811Q41665481-12853B60-3635-4ED7-882D-9C9E6C32C8F3Q42910852-DB8427EC-CD1A-4152-9825-EFF5A6CBAF5CQ44585972-00CCE3BA-66D0-4852-8A4B-7407C63F02C7Q45018813-C56916AB-B029-4B51-ADA5-109BAC95F0CBQ46818183-CB85AAD2-681F-4258-A6C5-6A12FE192C71Q53158556-AAA60AFD-6F5F-4DA0-9A4E-78313A4B46EF
P2860
Clinico-biological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Clinico-biological characteriz ...... lymphoma in the rituximab era.
@en
Clinico-biological characteriz ...... lymphoma in the rituximab era.
@nl
type
label
Clinico-biological characteriz ...... lymphoma in the rituximab era.
@en
Clinico-biological characteriz ...... lymphoma in the rituximab era.
@nl
prefLabel
Clinico-biological characteriz ...... lymphoma in the rituximab era.
@en
Clinico-biological characteriz ...... lymphoma in the rituximab era.
@nl
P2093
P2860
P50
P1433
P1476
Clinico-biological characteriz ...... lymphoma in the rituximab era.
@en
P2093
Adriana García-Herrera
Antonio Martínez
Armando López-Guillermo
Emilio Montserrat
Gabriela Ghita
Lluis Colomo
Neus Villamor
Pau Abrisqueta
Sonia Rodríguez
P2860
P304
P356
10.3109/10428194.2010.483301
P577
2010-07-01T00:00:00Z